iShares US Pharmaceuticals ETF
97 hedge funds and large institutions have $348M invested in iShares US Pharmaceuticals ETF in 2017 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 26 increasing their positions, 35 reducing their positions, and 11 closing their positions.
55% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 11
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
26% more capital invested
Capital invested by funds: $276M → $348M (+$71.3M)
24.64% more ownership
Funds ownership: 120.84% → 145.48% (+25%)
5% more funds holding
Funds holding: 92 → 97 (+5)
26% less repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 35
Top Buyers
Top Sellers
| 1 |
BWL
Bogart Wealth LLC
Mclean,
Virginia
|
-$12.4M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$8.87M |
| 3 |
Morgan Stanley
New York
|
-$6.58M |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$2.68M |
| 5 |
TC
Telemus Capital
Southfield,
Michigan
|
-$2.31M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
MLIC
101
Mandatum Life Insurance Company
Helsinki,
Finland
| – | -$227K | -4,824 | Closed |
|
|
SIG
102
Stanford Investment Group
Mountain View,
California
| – | -$60K | -1,269 | Closed |
|
|
EDRH
103
Edmond de Rothschild Holding
Chambesy,
Switzerland
| – | -$24K | -525 | Closed |
|
|
PMFA
104
Plante Moran Financial Advisors
Southfield,
Michigan
| – | -$23K | -495 | Closed |
|
|
KTC
105
Kistler-Tiffany Companies
Berwyn,
Pennsylvania
| – | -$12K | -264 | Closed |
|
|
WB
106
Webster Bank
Waterbury,
Connecticut
| – | -$12K | -249 | Closed |
|
107
UBS AM
Chicago,
Illinois
| – | -$9K | -195 | Closed |
|
IHE Hedge Fund Activity: Q1 2017 in Review
97 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in iShares US Pharmaceuticals ETF (IHE) for Q1 2017, worth a combined $348M — up 26% from $276M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new IHE positions and 11 closed out — a net gain of 6 holders — while 26 added to existing stakes and 35 trimmed.
The largest buyer was Clal Insurance, adding an estimated $66.8M. The largest seller was Bogart Wealth LLC, exiting entirely with an estimated $12.4M sold.
- 97 institutional investors held iShares US Pharmaceuticals ETF (IHE) as of Q1 2017, up from 92 in Q4 2016.
- Funds reported $348M of iShares US Pharmaceuticals ETF stock for Q1 2017, up 26% quarter-over-quarter.
- 17 funds opened new iShares US Pharmaceuticals ETF positions in Q1 2017 and 11 closed out, a net change of +6 holders.
- The largest iShares US Pharmaceuticals ETF buyer in Q1 2017 was Clal Insurance, an estimated $66.8M added.
- The largest iShares US Pharmaceuticals ETF seller in Q1 2017 was Bogart Wealth LLC, an estimated $12.4M sold.
Based on aggregated 13F filings for Q1 2017.